Work

Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”

Year: 2017

Type: article

Abstract: Authors’ reply Hermann Brenner 1–3 Hongda Chen 1,4 1 Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), 2 Division of Preventive Oncology, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT), 3 German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany; 4 Program Office for Cancer Screening in Urban China, National Cancer Center/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Chaoyang District, Beijing, People’s Republic of China We appreciate Dr. Ahlquist’s interest in our article 1 that challenges his previously disseminated claim that the multitarget stool DNA test (MSDT) represents “the new high bar benchmark for noninvasive CRC screening”. 2 View the original paper by Brenner and Chen.

Source: Clinical Epidemiology

DOI: 10.2147/clep.s148780

Author: David Ahlquist

Institution: Mayo Clinic

Language: English

Topic: Colorectal Cancer Screening and Detection

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,836